of folic acid to DHF and DFH to THF (see Figures 7.9 and 7.12). Trimethoprim
binds to bacterial DHFR but not human DHFR because of differences in the
structures of these enzymes due to difference in species (Appendix 12). These
observations led to the development of co-trimoxazole, a mixture of one part
trimethoprim and five parts sulphamethoxazole, to treat bacterial infections
Sulphamethoxazole Trimethoprim
Blocks this
step
Blocks this
step
PABA Folic acid DHF THF
Blocks this
step
CH 2
NH 2
N
N
H 2 N
OCH 3
OCH 3
OCH 3
SO 2 NH CH 3
NO
H 2 N
Figure 7.12 Sequential blocking using sulphamethoxazole and trimethoprim
7.5.3 Intercalation agents
Intercalating agents are compounds that insert themselves between the bases of
the DNA helix (Figure 7.13(a) ). The insertion causes the DNA helix to partially
unwind at the site of the intercalated molecule. This inhibits transcription, which
blocks the replication process of the cell. Although the mechanism of this
inhibition is not known, inhibition of cell replication can lead to cell death
and an improvement in the health of the patient.
The DNA begins
to unwind
Intercalating
agent
Normal DNA
(a)
Cl N
NHCHCH 2 CH 2 CH 2 N
CH 3
CH 2 CH 3
CH 2 CH 3
Chloroquine (antimalarial)
O
O
OH
OH
NH(CH 2 ) 2 NH(CH 2 ) 2 OH
NH(CH 2 ) 2 NH(CH 2 ) 2 OH
Mitoxantrone, Novanatrone*
(anticancer)
H 2 N N NH 2
Proflavine (3,6-diaminoacridine)
(antibiotic)
CH=CH 2
CH 3 O
HO N
N
H
H
Quinine (antimalarial)
(b)
Figure 7.13 (a) A schematic representation of the action of intercalation agents. The horizontal
dotted lines represent the complementary base pairs. The rings of these bases and the intercalating
agent are on edge to the reader. (b) Examples of intercalating agents.*Trade name
DRUGS THAT TARGET NUCLEIC ACIDS 151